Faecal microbiota transplant: A novel biological approach to extensively drug-resistant organism-related non-relapse mortality

Bone Marrow Transplantation

Volumn 52, Issue 10, 2017, Pages 1452-1454

  Innes, A J ^a,b   Mullish, B H ^a   Fernando, F ^b   Adams, G ^b   Marchesi, J R ^a,c   Apperley, J F ^a,b   Brannigan, E ^b   Davies, F ^b   Pavlu J ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; COLISTIN; CYCLOSPORIN; IMATINIB; METHOTREXATE; METOCLOPRAMIDE; NEOMYCIN; OMEPRAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN; ANTINEOPLASTIC AGENT; ASPARAGINASE; DAUNORUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BLOODSTREAM INFECTION; CASE REPORT; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; ENTEROCOCCAL INFECTION; ESCHERICHIA COLI INFECTION; FECAL MICROBIOTA TRANSPLANTATION; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; MALE; MIDDLE AGED; MORTALITY; NON RELAPSE MORTALITY; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA; ALLOGRAFT; ANTIBIOTIC RESISTANCE; BACTERIUM; FATALITY; FECES; GROWTH, DEVELOPMENT AND AGING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHILADELPHIA 1 CHROMOSOME;

ALLOGRAFTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BACTERIA; DAUNORUBICIN; DRUG RESISTANCE, BACTERIAL; FATAL OUTCOME; FECAL MICROBIOTA TRANSPLANTATION; FECES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISOLONE; VINCRISTINE;

EID: 85030684961     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2017.151     Document Type: Letter

References (17)

1. Cantón R, Akova M, Carmeli Y, Giske C, Glupczynski Y, Gniadkowski M et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012; 18: 413-431.
2. Satlin MJ, Cohen N, Ma KC, Chen L, Kreiswirth BN, Walsh TJ et al. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect 2016; 73: 336-345.
3. Bilinski J, Robak K, Peric Z, Marchel H, Karakulska-Prystupiuk E, Halaburda K et al. Impact of gut colonization by antibiotic-resistant bacteria on the outcomes of allogeneic hematopoietic stem cell transplantation: a retrospective, single-center study. Biol Blood Marrow Transplant 2016; 22: 1087-1093.
4. Fielding AK, Rowe JM, Buck G, Foroni L, Gerrard G, Litzow MR et al. UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. Blood 2014; 123: 843-850.
5. Huttner B, Haustein T, Uçkay I, Renzi G, Stewardson A, Schaerrer D et al. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 2013; 68: 2375-2382.
6. Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infect Control 2013; 41: 1167-1172.
7. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415.
8. Webb BJ, Brunner A, Ford CD, Gazdik MA, Petersen FB, Hoda D. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis 2016; 18: 628-633.
9. Millan B, Park H, Hotte N, Mathieu O, Burguiere P, Tompkins TA et al. Fecal microbial transplants reduce antibiotic-resistant genes in patients with recurrent Clostridium difficile infection. Clin Infect Dis 2016; 62: 1479-1486.
10. Manges AR, Steiner TS, Wright AJ, Manges AR, Steiner TS, Faecal AJW. Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review. Infect Dis 2016; 48: 587-592.
11. Bilinski J, Grzesiowski P, Sorensen N, Madry K, Muszynski J, Robak K et al. Fecal microbiota transplantation in patients with blood disorders inhibits gut colonization with antibiotic-resistant bacteria: results of a prospective, single-center study. Clin Infect Dis (e-pub ahead of print 24 March 2017; doi: 10.1093/cid/cix252).
12. Mullish BH, Marchesi JR, Thursz MR, Williams HRT. Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection. QJM 2015; 108: 355-359.
13. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium diffi cile infection. Am J Gastroenterol 2012; 107: 761-767.
14. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis 2011; 17: 1791-1798.
15. Liu Y-Y, Wang Y, Walsh TR, Yi L-X, Zhang R, Spencer J et al. Emergence of plasmidmediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16: 161-168.
16. Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013; 14: 685-690.
17. Biliński J, Grzesiowski P, Muszyński J, Wróblewska M, Mądry K, Robak K et al. Fecal microbiota transplantation inhibits multidrug-resistant gut pathogens: preliminary report performed in an immunocompromised host. Arch Immunol Ther Exp 2016; 64: 255-258.